Kardiorenal effekt i TARGET (12 måneders studie) For det systoliske blodtryk var den gennemsnitlige ændring fra basislinien +0, 4 mmHg for lumiracoxib og +2, 1 mmHg for NSAID (p < 0, 0001).
17 For systolic blood pressure, mean change from baseline were +0.4 mmHg for lumiracoxib and +2.1 mmHg for NSAIDs (p < 0.0001).